Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2010-08-17
Original SEC Filing: Click here

---

Webplus: BSPM/20100817/8-K/2_EX-99.1/000.htm SEC Original: ex99-1.htm
BIOSTAR PHARMACEUTICALS, SECOND QUARTER REVENUEREASED 46.4% TO $19.4 MILLION XIANYANG, China, August 17, 2010 – Q2 2010 revenuereased 46.4% to $19.4 million – Q2 2010 Non-GAAPjusted netomereased 50.9% to $5.8 million withjusted EPS of $0.21 – Biostar reiterates guidance for 2010: Revenue expected to be between $80.0 to $82.0 million and netome between $18.0 to

---

---

Webplus: BSPM/20100817/8-K/1/000.htm SEC Original: biostarpharma8k081710.htm
FORM 8-K CURRENT REPORTte of report (Date of earliest event reported): August 17, 2010 BIOSTAR PHARMACEUTICALS, Maryland 001-34708 20-8747899 (State or other jurisdiction oforporation or organization) (Commission File No.) (IRS Employer Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Province Peoples Republic of China 712046 86-029-33686638 (Issuer Telephone Number)

---

Company Information:

Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2010-08-17CIK: 0001418133, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 588 SHIJI XI AVENUE
XIANYANG, SHAANXI PROVINCE 712046